Cargando…

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS

OBJECTIVE: To evaluate the clinical relevance of myelin oligodendrocyte glycoprotein antibody (MOG-Ab) in a cohort of adults with inflammatory demyelinating disease (IDD) of the CNS. METHODS: Live cell-based assays for MOG-Ab (IgG1 subset) and antibody to aquaporin-4 (AQP4-Ab) were performed in a co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sung-Min, Woodhall, Mark R., Kim, Ji-Sun, Kim, Seong-Joon, Park, Kyung Seok, Vincent, Angela, Lee, Kwang-Woo, Waters, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608758/ https://www.ncbi.nlm.nih.gov/pubmed/26516628 http://dx.doi.org/10.1212/NXI.0000000000000163

Ejemplares similares

Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status
por: Kim, Sung-Min, et al.
Publicado: (2014)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
por: Ren, Bing-Yan, et al.
Publicado: (2021)

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
por: Schanda, Kathrin, et al.
Publicado: (2021)

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies
por: Morris, Katrina A., et al.
Publicado: (2015)

MOG antibodies in combined central and peripheral demyelination syndromes
por: Vazquez Do Campo, Rocio, et al.
Publicado: (2018)

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
por: Yeo, Tianrong, et al.
Publicado: (2020)

The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination
por: Kinzel, Silke, et al.
Publicado: (2017)

Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
por: Wendel, Eva Maria, et al.
Publicado: (2022)

Predictors of relapse in MOG antibody associated disease: a cohort study
por: Huda, Saif, et al.
Publicado: (2021)

Swimming Exercise Ameliorates Symptoms of MOG-Induced Experimental Autoimmune Encephalomyelitis by Inhibiting Inflammation and Demyelination in Rats
por: Kim, Ji-Youn, et al.
Publicado: (2020)

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
por: Ramanathan, Sudarshini, et al.
Publicado: (2018)

Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies
por: Lee, Haeng-Jin, et al.
Publicado: (2018)

Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
por: Dale, Russell C., et al.
Publicado: (2014)

Brain histopathological study and prognosis in MOG antibody‐associated demyelinating pseudotumor
por: Shu, Yaqing, et al.
Publicado: (2019)

COVID-19 vaccine associated demyelination & its association with MOG antibody
por: Netravathi, M., et al.
Publicado: (2022)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
por: Jurynczyk, Maciej, et al.
Publicado: (2017)

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
por: Waters, Patrick, et al.
Publicado: (2015)

Peripherally derived macrophages as major phagocytes in MOG encephalomyelitis
por: Kwon, Young Nam, et al.
Publicado: (2019)

International multicenter examination of MOG antibody assays
por: Reindl, Markus, et al.
Publicado: (2020)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
por: Pace, Samuel, et al.
Publicado: (2022)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination
por: Berg, Carsten Tue, et al.
Publicado: (2017)

Treatment Approaches for MOG-Ab-Associated Demyelination in Children
por: Hacohen, Yael, et al.
Publicado: (2019)

Epitope specificity of demyelinating MOG-specific autoantibody responses
por: Brehm, U., et al.
Publicado: (1998)

Defining distinct features of anti-MOG antibody associated central nervous system demyelination
por: Weber, Martin S., et al.
Publicado: (2018)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
por: Cross, Helen, et al.
Publicado: (2021)

Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations
por: Kim, Ki Hoon, et al.
Publicado: (2022)

A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
por: Hochmeister, Sonja, et al.
Publicado: (2020)

Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases
por: Serguera, Che, et al.
Publicado: (2019)

Refractory MOG-Associated Demyelinating Disease in a Pediatric Patient
por: Kroenke, Eve, et al.
Publicado: (2022)

Tumefactive Demyelination—A Rare Presentation of Anti-MOG Syndrome
por: Sivadasan, Sesh, et al.
Publicado: (2022)

Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis
por: Hyun, Jae-Won, et al.
Publicado: (2018)

A multicenter comparison of MOG-IgG cell-based assays
por: Waters, Patrick J., et al.
Publicado: (2019)

Anti-MOG encephalitis mimicking small vessel CNS vasculitis
por: Patterson, Kristina, et al.
Publicado: (2019)

T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity
por: Sagan, Sharon A., et al.
Publicado: (2023)

Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies
por: Hyun, Jae-Won, et al.
Publicado: (2020)

Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria
por: Fadda, Giulia, et al.
Publicado: (2022)

Measles–rubella vaccine–associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child
por: Otiv, Madhumati, et al.
Publicado: (2022)

alpha-Synuclein: a Modulator During Inflammatory CNS Demyelination
por: Kuhbandner, Kristina, et al.
Publicado: (2020)

Sentinel inflammatory demyelinating lesions preceding primary CNS lymphoma
por: TORRES, Danielle Mesquita, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ffm6376mj1phdm70b80ug94ha1